These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 27085944

  • 1. Design and synthesis of some novel 4-Chloro-N-(4-(1-(2-(2-cyanoacetyl)hydrazono)ethyl)phenyl) benzenesulfonamide derivatives as anticancer and radiosensitizing agents.
    Ghorab MM, Ragab FA, Heiba HI, Soliman AM.
    Eur J Med Chem; 2016 Jul 19; 117():8-18. PubMed ID: 27085944
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
    Ghorab MM, Ragab FA, Heiba HI, El-Gazzar MG, Zahran SS.
    Eur J Med Chem; 2015 Mar 06; 92():682-92. PubMed ID: 25618015
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents.
    Ghorab MM, Ragab FA, Heiba HI, Youssef HA, El-Gazzar MG.
    Bioorg Med Chem Lett; 2010 Nov 01; 20(21):6316-20. PubMed ID: 20850308
    [Abstract] [Full Text] [Related]

  • 4. Anticancer and radiosensitizing evaluation of some new pyranothiazole-Schiff bases bearing the biologically active sulfonamide moiety.
    Ghorab MM, Shaaban MA, Refaat HM, Heiba HI, Ibrahim SS.
    Eur J Med Chem; 2012 Jul 01; 53():403-7. PubMed ID: 22583778
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, in-vitro anticancer screening and radiosensitizing evaluation of some new N-(quinoxalin-2-yl)benzenesulfonamide derivatives.
    Ghorab MM, Ragab FA, Heiba HI, El-Gazzar MG, El-Gazzar MG.
    Arzneimittelforschung; 2012 Jan 01; 62(1):46-52. PubMed ID: 22331763
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, in vitro anticancer screening and radiosensitizing evaluation of some new 4-[3-(substituted)thioureido]-N-(quinoxalin-2-yl)-benzenesulfonamide derivatives.
    Ghorab MM, Ragab FA, Heiba HI, El-Gazzar MG, El-Gazzar MG.
    Acta Pharm; 2011 Dec 01; 61(4):415-25. PubMed ID: 22202200
    [Abstract] [Full Text] [Related]

  • 7. Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitors.
    Ghorab MM, Ragab FA, Heiba HI, El-Gazzar MG, El-Gazzar MGM.
    Bioorg Med Chem Lett; 2018 May 15; 28(9):1464-1470. PubMed ID: 29628325
    [Abstract] [Full Text] [Related]

  • 8. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety.
    Ghorab MM, Ragab FA, Heiba HI, Arafa RK, El-Hossary EM.
    Eur J Med Chem; 2010 Sep 15; 45(9):3677-84. PubMed ID: 20684857
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, anticancer activity and radiosensitizing evaluation of some new 2-pyridone derivatives.
    El-Said MS, El-Gazzar MG, Al-Dosari MS, Ghorab MM.
    Arzneimittelforschung; 2012 Mar 15; 62(3):149-56. PubMed ID: 22270843
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety.
    Al-Dosari MS, Ghorab MM, Alsaid MS, Nissan YM, Ahmed AB.
    Eur J Med Chem; 2013 Nov 15; 69():373-83. PubMed ID: 24077528
    [Abstract] [Full Text] [Related]

  • 11. Utility of methyl 2-isothiocyanatobenzoate in the synthesis of some new quinazoline derivatives as potential anticancer and radiosensitizing agents.
    Ghorab MM, Ragab FA, Heiba HI, Bayomi AA.
    Arzneimittelforschung; 2011 Nov 15; 61(12):719-26. PubMed ID: 22282960
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Study of reactivity of cyanoacetohydrazonoethyl-N-ethyl-N-methyl benzenesulfonamide: preparation of novel anticancer and antimicrobial active heterocyclic benzenesulfonamide derivatives and their molecular docking against dihydrofolate reductase.
    Debbabi KF, Al-Harbi SA, Al-Saidi HM, Aljuhani EH, Abd El-Gilil SM, Bashandy MS.
    J Enzyme Inhib Med Chem; 2016 Nov 15; 31(sup4):7-19. PubMed ID: 27557134
    [Abstract] [Full Text] [Related]

  • 14. Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety.
    Ghorab MM, Ragab FA, Heiba HI, El-Hazek RM.
    Eur J Med Chem; 2011 Oct 15; 46(10):5120-6. PubMed ID: 21890248
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis of some novel quinolines and pyrimido [4,5-b] quinolines bearing A sulfonamide moiety as potential anticancer and radioprotective agents.
    Ghorab MM, Ragab FA, Noaman E, Heiba HI, El-Hossary EM.
    Arzneimittelforschung; 2007 Oct 15; 57(12):795-803. PubMed ID: 18380413
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, and antitumor screening of certain novel tetrahydroquinoline sulfonamides.
    Alafeefy AM.
    J Enzyme Inhib Med Chem; 2015 Apr 15; 30(2):189-94. PubMed ID: 24666309
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis, QSAR studies, and metabolic stability of novel 2-alkylthio-4-chloro-N-(5-oxo-4,5-dihydro-1,2,4-triazin-3-yl)benzenesulfonamide derivatives as potential anticancer and apoptosis-inducing agents.
    Żołnowska B, Sławiński J, Pogorzelska A, Szafrański K, Kawiak A, Stasiłojć G, Belka M, Zielińska J, Bączek T.
    Chem Biol Drug Des; 2017 Sep 15; 90(3):380-396. PubMed ID: 28122174
    [Abstract] [Full Text] [Related]

  • 20. DESIGN, SYNTHESIS AND ANTICANCER ACTIVITY OF SOME NOVEL 1,2,4-TRIAZOLES CARRYING BIOLOGICALLY ACTIVE SULFONAMIDE MOIETIES.
    Ghorab MM, Alsaid MS, Al-Dosari M.
    Acta Pol Pharm; 2016 Sep 15; 73(5):1147-1153. PubMed ID: 29638055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.